GOLDENBERG GARY sold 9.3% of their position (8.85K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $26.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/16/2023ACC: 0001209191-23-055534
Director
Since Jun 2019
-8.85K
Net shares
Net seller
$26.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.82K
Price / share
$2.93
Trade value
$17.04K
% of position
6.1%
11/14/2023
95.11K→89.29K
Common Stock
Direct
Shares
−3.04K
Price / share
$2.97
Trade value
$9.02K
% of position
3.4%
11/15/2023
89.29K→86.26K
Total
Net shares
−8.85K
Net value
-$26.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/14/2023 | S · Sale | −5.82K | $2.93 | $17.04K | 6.1% | 95.11K | 89.29K |
| Common Stock Direct | 11/15/2023 | S · Sale | −3.04K | $2.97 | $9.02K | 3.4% | 89.29K | 86.26K |
| Total | −8.85K | -$26.06K | ||||||
Derivative Transactions0
No derivative transactions reported